Tumour-infiltrating NK cells and γδ T-cells for cellular immunotherapy

The frequent downregulation or complete loss of major histocompatibility complex (MHC) expression by tumour cells often compromises patients’ response to standard cancer treatments or αβ T-cell-based therapies. Thus, NK cell and ɣδ T-cell-based cancer immunotherapies emerged as complementary treatme...

ver descrição completa

Detalhes bibliográficos
Autor principal: Condeço, Ana Carolina Grais (author)
Formato: masterThesis
Idioma:eng
Publicado em: 2021
Assuntos:
Texto completo:http://hdl.handle.net/10362/112051
País:Portugal
Oai:oai:run.unl.pt:10362/112051